Skip to content
Tuesday 1 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,789.28
-0.32%
DAX
25,970.11
-1.10%
CAC 40
8,301.85
-0.39%
STOXX 50
6,368.98
-0.80%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Thursday 12 August 2010 7:48 pm

Investors flock to defensive stocks as FTSE inches higher

By: KCS-content

Add as a preferred source on Google

BRITAIN’S top share index ended higher yesterday after defensives gained, led by pharma firm GlaxoSmithKline after US authorities recommended approval of its Potiga epilepsy drug.

The FTSE 100 ended up 20.85 points, or 0.4 per cent, at 5,266.06, having hit its lowest close in three weeks on Wednesday when it fell 2.4 per cent to 5,245.21.

Trade was choppy in the top index, however, as investors remained wary of the wider economic malaise, with the index fluctuating between a high of 5,273 and a low of 5,211.

The FTSE 250, meanwhile, closed down 66.18 points, or 0.67 per cent, to 9,788.31. The FTSE SmallCap index fell 16 points, or 0.57 per cent, to 2,774.71.

Volumes were low, as investors were cautious on the economic outlook following weak data on both sides of the Atlantic in August after some strong corporate data in July helped drive a 6.9 per cent gain for the month.

“After the rally in July on decent corporate data the positive newsflow has dried up and the lack of good news has left the field clear for those who think there will be a double dip recession,” said Jim Wood-Smith, head of research at Williams de Broe.

On individual issues, GlaxoSmithKline added 2.6 per cent after US advisers recommended approval of Potiga, a new epilepsy drug developed with Valeant Pharmaceuticals, which in turn led a number of defensive stocks to modest gains. Glaxo peer AstraZeneca rose 0.7 per cent, while consumer goods group Unilever climbed 1.4 per cent and British American Tobacco rose 1.0 per cent. Energy supplier Centrica was the top gainer, up 3.3 per cent.

Miners recovered from early weakness, tracking rebounding metal prices, with Rio Tinto and Xstrata both up 0.3 per cent.

Randgold Resources added 2.4 per cent as gold neared a four-week high on safe-haven buying. African Barrick Gold also put on 2.7 per cent.

India-focused mining group Vedanta Resources was the top loser, however, slipping 7.5 per cent on news it was in talks to buy assets or take a multibillion-dollar equity stake in British oil and gas exploration company Cairn Energy.

Insurers were the biggest sector drag on the index, with Old Mutual down 1.9 per cent after Goldman Sachs cuts its rating on the stock, citing weakness in the South African economy.

Aero engineer Hampson Industries tumbled 61 per cent to 20p, its lowest level since March 2003, after the firm warned full-year profit would be materially below market estimates. Bank note printer De La Rue was another high profile faller, down 10.4 per cent, due to the resignation of its chief executive. James Hussey stepped down following disappointing sales and problems with its bank note printing presses.

Meanwhile, shares in London black cab maker Manganese Bronze plunged 11 per cent after the group announced that China’s Geely had pulled out of financing plans that would have seen it take a controlling stake in the group. Geely – which already owns 23 per cent of Manganese –had been in lengthy talks over a share placing to provide Manganese with financing in return for a 51 per cent stake. But the firm stressed that its international growth plans were still on track.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Money

Related Topics

  • NULL

Trending Articles

  • ‘Misleading’ Frasers ad banned amid feud with watchdog 

  • UK economy stuck in ‘slow lane’ as business investment to slump 

  • Meraki Capital Launches Tessero Across Six European Markets Following Landmark Hays Acquisition

  • Lost Village festival review: is this posher than Wilderness?

  • FOMO drives Premier League clubs to new record summer spending of over £3bn

More from Morning Wire

  • FTSE 100 creeps closer to record high as investors dodge AI turmoil

    Markets
    The FTSE 100 enjoyed a 3-year record rally in the third quarter.
  • As it happened: FTSE 100 climbs as markets digest Bessent buyback

    Markets
    Scott Bessent, a man with gray hair and glasses, wearing a blue suit and striped tie, looking to the side.
  • As it happened: FTSE 100 jumps in best streak since May; Vistry, Melrose lead risers

    FTSE 100 Live
    LSEG signage and digital stock market ticker displays inside a modern financial building.
  • As it happened: Miners fuel FTSE 100 recovery; oil jumps as Trump claims Strait of Hormuz

    FTSE 100 Live
    FTSE 100 stocks rise as Brent crude oil prices jump 1.8% to $104.98 amid Strait of Hormuz tensions and Trumps Iran stance
  • As it happened: FTSE 100 rallies after JD Sports drags on blue chips; oil jumps again

    FTSE 100 Live
    Londons Stock Exchange orb with FTSE 100 display, symbolizing business and market updates
  • As it happened: Stocks reach all-time high; US fires back at ‘surprise’ Iran attacks

    Markets
    LSEG logo on a large screen within a modern building displaying stock market data and world indices
  • As it happened: FTSE 100 falls but Nasdaq soars after Nvidia sales boom

    FTSE 100 Live
    Smiling man with gray hair and glasses in a dark suit and blue tie, speaking at an event.
  • As it happened: Stocks rally; US to unveil ‘economic D-Day’ Iran sanctions

    FTSE 100 Live
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook